Business Description
Daan Gene Co Ltd
NAICS : 325199
ISIN : CNE000001KP1
Share Class Description:
SZSE:002030: Class ACompare
Compare
Traded in other countries / regions
002030.China IPO Date
2004-08-09Description
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.31 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -1 | |||||
Interest Coverage | 3.52 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 3.86 | |||||
Beneish M-Score | -0.35 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39.5 | |||||
3-Year EBITDA Growth Rate | -45.6 | |||||
3-Year FCF Growth Rate | -54.1 | |||||
3-Year Book Growth Rate | 27.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.98 | |||||
9-Day RSI | 40.68 | |||||
14-Day RSI | 36.11 | |||||
6-1 Month Momentum % | -39.09 | |||||
12-1 Month Momentum % | -42.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.74 | |||||
Quick Ratio | 3.57 | |||||
Cash Ratio | 0.56 | |||||
Days Inventory | 240.49 | |||||
Days Sales Outstanding | 902.99 | |||||
Days Payable | 333.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.3 | |||||
Dividend Payout Ratio | 36.46 | |||||
3-Year Dividend Growth Rate | 378.2 | |||||
Forward Dividend Yield % | 0.3 | |||||
5-Year Yield-on-Cost % | 83.99 | |||||
Shareholder Yield % | -1.55 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.76 | |||||
Operating Margin % | 3.73 | |||||
Net Margin % | -28.43 | |||||
FCF Margin % | 56.58 | |||||
ROE % | -3.14 | |||||
ROA % | -2.53 | |||||
ROIC % | 0.38 | |||||
ROC (Joel Greenblatt) % | -7.6 | |||||
ROCE % | -3.65 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 102.71 | |||||
Shiller PE Ratio | 5.73 | |||||
PEG Ratio | 1.84 | |||||
PS Ratio | 6.67 | |||||
PB Ratio | 0.81 | |||||
Price-to-Tangible-Book | 0.91 | |||||
Price-to-Free-Cash-Flow | 11.79 | |||||
Price-to-Operating-Cash-Flow | 6.58 | |||||
EV-to-EBIT | -18.02 | |||||
EV-to-EBITDA | -18.02 | |||||
EV-to-Revenue | 6.24 | |||||
EV-to-FCF | 11.34 | |||||
Price-to-Projected-FCF | 0.32 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Price-to-Graham-Number | 2.04 | |||||
Price-to-Net-Current-Asset-Value | 1.9 | |||||
Earnings Yield (Greenblatt) % | -5.55 | |||||
FCF Yield % | 8.49 | |||||
Forward Rate of Return (Yacktman) % | 40.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daan Gene Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,038.167 | ||
EPS (TTM) (Â¥) | -0.211 | ||
Beta | 0.76 | ||
Volatility % | 42.02 | ||
14-Day RSI | 36.11 | ||
14-Day ATR (Â¥) | 0.172321 | ||
20-Day SMA (Â¥) | 5.052 | ||
12-1 Month Momentum % | -42.74 | ||
52-Week Range (Â¥) | 4.72 - 11 | ||
Shares Outstanding (Mil) | 1,403.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Daan Gene Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Daan Gene Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Daan Gene Co Ltd Frequently Asked Questions
What is Daan Gene Co Ltd(SZSE:002030)'s stock price today?
The current price of SZSE:002030 is ¥4.93. The 52 week high of SZSE:002030 is ¥11.00 and 52 week low is ¥4.72.
When is next earnings date of Daan Gene Co Ltd(SZSE:002030)?
The next earnings date of Daan Gene Co Ltd(SZSE:002030) is .
Does Daan Gene Co Ltd(SZSE:002030) pay dividends? If so, how much?
The Dividend Yield %  of Daan Gene Co Ltd(SZSE:002030) is 0.3% (As of Today), Highest Dividend Payout Ratio of Daan Gene Co Ltd(SZSE:002030) was 36.46. The lowest was 0.01. And the median was 0.34. The  Forward Dividend Yield % of Daan Gene Co Ltd(SZSE:002030) is 0.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |